FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
CIPRO
ciprofloxacin
LOE Approaching
Bayer
INJECTION · INJECTABLE
infections caused by susceptible isolates of the designated microorganisms in the specific condition listed below: Acute Otitis Media (AOM) in pediatric patients (age 6 monthsolder) with tympanostomy tubes due to Staphylococcus aureus+4
1990
SMNDA30/100
CIPRO HC
ciprofloxacin hydrochloride and hydrocortisone
LOE Approaching
Novartis
OTIC · SUSPENSION/DROPS
acute otitis externa in adultone year+4
1998
NDA30/100
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
ciprofloxacin
LOE Approaching
Bayer
INJECTION · INJECTABLE
infections caused by susceptible isolates of the designated microorganisms in the specific condition listed below: Acute Otitis Media (AOM) in pediatric patients (age 6 monthsolder) with tympanostomy tubes due to Staphylococcus aureus+4
1990
SMNDA30/100
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
ciprofloxacin
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
infections caused by susceptible isolates of the designated microorganisms in the specific condition listed below: Acute Otitis Media (AOM) in pediatric patients (age 6 monthsolder) with tympanostomy tubes due to Staphylococcus aureus+4
1990
SMNDA30/100
CIPRO XR
ciprofloxacin; ciprofloxacin hydrochloride
LOE Approaching
Bayer
ORAL · TABLET, EXTENDED RELEASE
infections caused by susceptible isolates of the designated microorganisms in the specific condition listed below: Acute Otitis Media (AOM) in pediatric patients (age 6 monthsolder) with tympanostomy tubes due to Staphylococcus aureus+4
2002
NDA30/100
CIPRO XR
ciprofloxacin; ciprofloxacin hydrochloride
LOE Approaching
R-Pharm US
ORAL · TABLET, EXTENDED RELEASE
infections caused by susceptible isolates of the designated microorganisms in the specific condition listed below: Acute Otitis Media (AOM) in pediatric patients (age 6 monthsolder) with tympanostomy tubes due to Staphylococcus aureus+4
2003
NDA30/100
CIPRODEX
ciprofloxacin and dexamethasone
LOE Approaching
Novartis
OTIC · SUSPENSION/DROPS
infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below: • Acute Otitis Media (AOM) in pediatric patients (age 6 monthsolder) with tympanostomy tubes due to Staphylococcus aureus+4
2003
NDA30/100
CIS-MDP
tc 99m medronate
LOE Approaching
PharmaIN
INJECTION · INJECTABLE
1979
NDA30/100
CIS-PYRO
technetium tc99m pyrophosphate
LOE Approaching
PharmaIN
INJECTION · INJECTABLE
1987
NDA30/100
CISPLATIN
cisplatin
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
advanced testicular canceradvanced ovarian cancer+2
1978
NDA30/100
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
LOE Approaching
ORALLY DISINTEGRATING · TABLET
major depressive disorder (MDD) in adults ( )
2005
NDA30/100
CITANEST
prilocaine hydrochloride
LOE Approaching
AstraZeneca
INJECTION · INJECTABLE
1965
NDA30/100
CITANEST FORTE
epinephrine bitartrate; prilocaine hydrochloride
LOE Approaching
AstraZeneca
INJECTION · INJECTABLE
1965
NDA30/100
CITANEST FORTE DENTAL
epinephrine bitartrate; prilocaine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1965
NDA30/100
CITANEST PLAIN
prilocaine hydrochloride
LOE Approaching
AstraZeneca
INJECTION · INJECTABLE
1965
NDA30/100
CITANEST PLAIN DENTAL
prilocaine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1965
NDA30/100
CLAFORAN
cefotaxime sodium
LOE Approaching
INJECTION · INJECTABLE
1981
NDA30/100
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
cefotaxime sodium
LOE Approaching
INJECTION · INJECTABLE
1985
NDA30/100
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cefotaxime sodium
LOE Approaching
INJECTION · INJECTABLE
1985
NDA30/100
CLARINEX
desloratadine
LOE Approaching
Merck & Co.
ORAL · SYRUP
2004
NDA30/100
CLARINEX
desloratadine
LOE Approaching
Merck & Co.
Oral · Tablet
2002
NDA30/100
CLARINEX
desloratadine
LOE Approaching
Merck & Co.
ORAL · SOLUTION
2004
NDA30/100
CLARINEX
desloratadine
LOE Approaching
Merck & Co.
ORAL · TABLET, ORALLY DISINTEGRATING
2002
NDA30/100
CLARINEX
desloratadine
LOE Approaching
Merck & Co.
Oral · Tablet
2002
NDA30/100